Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andreas Seeber

Showing results (81-90 of 118) with videos related to

Pageof 12
Sort By:
Therapeutic Advances in Medical Oncology|October 7, 2021
Benefit of second-line therapy for advanced esophageal squamous cell carcinoma: a tri-center propensity score analysisMoritz Müller, Florian Posch, Dominik Kiem, et al.
BMJ Oncology|April 8, 2026
CXCR4 mRNA overexpression: an indicator of poor survival and predictor of response to immune checkpoint inhibitors in patients with metastatic colorectal cancerSepideh Gholami, Anwaar Saeed, Yasmine Baca, et al.
Life (Basel, Switzerland)|January 21, 2022
FGFR Pathway Inhibition in Gastric Cancer: The Golden Era of an Old Target?Csongor G Lengyel, Sadaqat Hussain, Andreas Seeber, et al.
Molecular Therapy. Oncology|April 10, 2024
Differential landscape of immune evasion in oncogenic RAS-driven primary and metastatic colorectal cancersEmil Lou, Joanne Xiu, Yasmine Baca, et al.
American Journal of Hematology|March 7, 2023
Tissue iron distribution in patients with anemia of inflammation: Results of a pilot studyLukas Lanser, Michaela Plaikner, Andrea Schroll, et al.
JCO Precision Oncology|January 31, 2025
Tailored Approaches in the Treatment of Patients With Colorectal Cancer Harboring Tropomyosin Receptor Kinase Fusion and Microsatellite Instability-High: A Case Report and Literature ReviewSamuel Kim, Malak Itani, Xiuli Liu, et al.
Translational Lung Cancer Research|January 24, 2022
Correlations between peripheral blood biomarkers and clinical outcomes in advanced non-small cell lung cancer patients who received immunotherapy-based treatmentsYuequan Shi, Xiaoyan Liu, Jia Liu, et al.
Cancers|May 28, 2020
<i>WRN</i>-Mutated Colorectal Cancer Is Characterized by a Distinct Genetic PhenotypeKai Zimmer, Alberto Puccini, Joanne Xiu, et al.
NPJ Precision Oncology|April 22, 2025
Multidimensional differences of right- and left-sided colorectal cancer and their impact on targeted therapiesMarwa Abdel Hamid, Lorenz M Pammer, Silvia Oberparleiter, et al.
Clinical and Translational Medicine|March 10, 2026
Multi-omic profiling defines three distinct molecular subtypes of urothelial carcinoma with implications for precision therapyNils C H van Creij, Piotr Tymoszuk, Florian Handle, et al.
Pageof 12

Showing results (81-90 of 118) with videos related to

Sort By:
Pageof 12
Therapeutic Advances in Medical Oncology|October 7, 2021
Benefit of second-line therapy for advanced esophageal squamous cell carcinoma: a tri-center propensity score analysisMoritz Müller, Florian Posch, Dominik Kiem, et al.
BMJ Oncology|April 8, 2026
CXCR4 mRNA overexpression: an indicator of poor survival and predictor of response to immune checkpoint inhibitors in patients with metastatic colorectal cancerSepideh Gholami, Anwaar Saeed, Yasmine Baca, et al.
Life (Basel, Switzerland)|January 21, 2022
FGFR Pathway Inhibition in Gastric Cancer: The Golden Era of an Old Target?Csongor G Lengyel, Sadaqat Hussain, Andreas Seeber, et al.
Molecular Therapy. Oncology|April 10, 2024
Differential landscape of immune evasion in oncogenic RAS-driven primary and metastatic colorectal cancersEmil Lou, Joanne Xiu, Yasmine Baca, et al.
American Journal of Hematology|March 7, 2023
Tissue iron distribution in patients with anemia of inflammation: Results of a pilot studyLukas Lanser, Michaela Plaikner, Andrea Schroll, et al.
JCO Precision Oncology|January 31, 2025
Tailored Approaches in the Treatment of Patients With Colorectal Cancer Harboring Tropomyosin Receptor Kinase Fusion and Microsatellite Instability-High: A Case Report and Literature ReviewSamuel Kim, Malak Itani, Xiuli Liu, et al.
Translational Lung Cancer Research|January 24, 2022
Correlations between peripheral blood biomarkers and clinical outcomes in advanced non-small cell lung cancer patients who received immunotherapy-based treatmentsYuequan Shi, Xiaoyan Liu, Jia Liu, et al.
Cancers|May 28, 2020
<i>WRN</i>-Mutated Colorectal Cancer Is Characterized by a Distinct Genetic PhenotypeKai Zimmer, Alberto Puccini, Joanne Xiu, et al.
NPJ Precision Oncology|April 22, 2025
Multidimensional differences of right- and left-sided colorectal cancer and their impact on targeted therapiesMarwa Abdel Hamid, Lorenz M Pammer, Silvia Oberparleiter, et al.
Clinical and Translational Medicine|March 10, 2026
Multi-omic profiling defines three distinct molecular subtypes of urothelial carcinoma with implications for precision therapyNils C H van Creij, Piotr Tymoszuk, Florian Handle, et al.
Pageof 12